Pfizer Inc
(TSX:PFE)
C$
10.63
-0.34 (-3.1%)
Market Cap: 191.93 Bil
Enterprise Value: 264.28 Bil
PE Ratio: 18.11
PB Ratio: 1.50
GF Score: 77/100 Pfizer Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 01:10PM GMT
Release Date Price:
C$22.53
(+2.36%)
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Okay. Great. Thank you. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and I have great pleasure to start with Dr. Dave Denton from Pfizer.
David M. Denton
Pfizer Inc. - CFO & Executive VP
I love it.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
And Chris Stevo from Pfizer. So Dave is the CFO of the Pfizer and he recently started in May of this year.
David M. Denton
Pfizer Inc. - CFO & Executive VP
Yes, exactly. Exactly.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
And Chris, I think it is almost a year for you.
Christopher J. Stevo;
Pfizer Inc. - Senior VP & Chief IR Officer
Correct. Just over a year actually.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot